Accenture plc ACN
NYSE · XNYS · stock
Chart by TradingView
5/9
Piotroski F — financial health
3.91
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $69.7B | $7.7B | — | $10.9B | $31.2B |
| 2024 | $64.9B | $7.3B | — | $8.6B | $29.2B |
| 2023 | $64.1B | $6.9B | — | $9.0B | $26.5B |
| 2022 | $61.6B | $6.9B | — | $8.8B | $22.7B |
| 2021 | $50.5B | $5.9B | — | $8.4B | $20.1B |
| 2020 | $44.3B | $5.1B | — | $7.6B | $17.5B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.91 (safe)
- Working capital / assets 0.131
- Retained earnings / assets 0.321
- EBIT / assets 0.156
- Equity / liabilities 0.912
Source: SEC EDGAR filings · CIK 0001467373 · as of 2025-08-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.